Alpha II’s technology integrates with electronic medical record, practice management, RCM and clearinghouse partners to support revenue cycle workflows for more than 100,000 clinicians, according to a May 25 TA news release. TA’s investment will support Alpha II’s continued development of its technology.
As part of the transaction, existing shareholder WestView Capital Partners will reinvest alongside TA to maintain a minority position in the company, according to the release. The transaction is expected to close in June.
